Characterization of nuclear-retained RNA-mediated gene regulatory mechanisms
Characterization of nuclear-retained RNA-mediated gene regulatory mechanisms
批准号:
10655466
负责人:
Prasanth Kumar Vijayan Kannanganattu
金额:
$30.17万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-15 至 2025-06-30
关键词:
AccelerationAlternative SplicingArginineAutomobile DrivingBindingBiologicalBiological AssayBiological ModelsBreast Cancer CellBreast Cancer TreatmentCancer ControlCell HypoxiaCell NucleusCell ProliferationCellsChromosome MappingClustered Regularly Interspaced Short Palindromic RepeatsCodeDataDefectEventExperimental ModelsFamilyFutureGene ExpressionGenesGenetic EngineeringGenetic TranscriptionGoalsHumanHuman GenomeHypoxiaKnowledgeLaboratoriesLocationMALAT1 geneMalignant NeoplasmsMammary NeoplasmsMapsMediatingMessenger RNAMissionModelingMolecularMouse Mammary Tumor VirusMusNeoplasm MetastasisNormal CellNuclearNuclear StructureOncogenicOutcomePathway interactionsPhasePhysiologicalPrognostic MarkerPropertyProteinsPublic HealthRNARNA ProcessingRNA SplicingRNA-Binding ProteinsRegulator GenesResearchRoleSerineSignal TransductionSpliced GenesTechniquesTestingTranscriptTumor TissueUnited States National Institutes of HealthUntranslated RNAangiogenesiscancer cellcell motilityexperimental studygenetic approachgenome-wideimaging approachimaging studyin vivoinnovationinsightintermolecular interactionknock-downmRNA Precursormalignant breast neoplasmmembermouse modelnew therapeutic targetoverexpressionpolyoma middle tumor antigenpreventprotein complexrecruitresponsescaffoldsuperresolution imagingtumortumor hypoxiatumor progressiontumorigenesisultra high resolution
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Human genome encodes a large number of non-protein coding RNA (ncRNA) genes, including thousands
long ncRNA (lncRNA) genes. MALAT1 is an abundant, conserved and nuclear speckle localized oncogenic
lncRNA that promotes breast tumor progression and metastasis. MALAT1 is induced during hypoxia, and
regulates the pre-mRNA alternative splicing (AS) of genes involved in hypoxia response. However, the
molecular mechanisms by which MALAT1 controls AS during hypoxia signaling, tumor progression and
metastasis remain to be elucidated. Genome-wide RNA mapping studies reveal that MALAT1 interacts with
transcriptionally active genes and their pre-mRNA. Further, MALAT1 interacts with several members of the
SR-family of splicing factors (SRSFs), and cells with deregulated expression of MALAT1 show defects in
SRSF levels and localization along with aberrant AS. The objective of the present proposal is to delineate
the molecular function of MALAT1 in SRSF-mediated AS, by utilizing hypoxia response as an experimental
model system. The central hypothesis is that MALAT1 by enriching SRSFs in nuclear speckles, modulates
the binding of SRSFs with their target pre-mRNAs and other speckle resident proteins. Guided by strong
preliminary data, this hypothesis will be tested in the following specific aims: 1) Determine how MALAT1
regulates SRSF-mediated alternative splicing (AS). 2) Determine the significance of nuclear speckle
enrichment of MALAT1 in mRNA processing. In the first aim, PI will determine how MALAT1 regulates the
binding and recruitment of SRSF1 (a prototypical member of SRSF proteins) to their target pre-mRNAs in
hypoxic breast cancer cells. PI will also determine the significance of MALAT1 during in vivo hypoxia
response using tumor mouse models. Under the second aim, PI by using super-resolution and live imaging
studies will determine the involvement of MALAT1 in the, 1) spatial organization of speckle components,
and 2) regulated localization of genes near speckles and AS. The approach is technically innovative,
because it employs state of the art cell biological techniques, including super-resolution imaging and genetic
approaches such as CRISPR/dCasRx-mediated RNA tethering assays. The proposed research is
significant because deciphering the role of MALAT1 in regulating the expression of genes will have broad
translational significance in the context of breast cancer treatment. Ultimately, this knowledge will pave way
to future studies utilizing MALAT1 as a novel therapeutic target against cancer.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Characterization of nuclear-retained RNA-mediated gene regulatory mechanisms
-
批准号:10414085
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2020
-
负责人:Prasanth Kumar Vijayan Kannanganattu
-
依托单位:
Characterization of nuclear-retained RNA-mediated gene regulatory mechanisms
-
批准号:10263902
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2020
-
负责人:Prasanth Kumar Vijayan Kannanganattu
-
依托单位:
Characterization of nuclear-retained RNA-mediated gene regulatory mechanisms
-
批准号:9887679
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2020
-
负责人:Prasanth Kumar Vijayan Kannanganattu
-
依托单位:
Characterization of nuclear-retained RNA-mediated gene regulatory mechanisms
-
批准号:10379740
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2020
-
负责人:Prasanth Kumar Vijayan Kannanganattu
-
依托单位:
Characterization of nuclear retained RNA-mediated gene regulatory mechanism
-
批准号:8436298
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2011
-
负责人:Prasanth Kumar Vijayan Kannanganattu
-
依托单位:
Characterization of nuclear retained RNA-mediated gene regulatory mechanism
-
批准号:8618908
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2011
-
负责人:Prasanth Kumar Vijayan Kannanganattu
-
依托单位:
Characterization of nuclear retained RNA-mediated gene regulatory mechanism
-
批准号:9024113
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2011
-
负责人:Prasanth Kumar Vijayan Kannanganattu
-
依托单位:
Characterization of nuclear retained RNA-mediated gene regulatory mechanism
-
批准号:8185975
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2011
-
负责人:Prasanth Kumar Vijayan Kannanganattu
-
依托单位:
Characterization of nuclear retained RNA-mediated gene regulatory mechanism
-
批准号:8296623
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2011
-
负责人:Prasanth Kumar Vijayan Kannanganattu
-
依托单位:
海外基金